Rang	Name	Position
1	Mr. Jan Moller Mikkelsen	President, CEO, Member of Executive Board & Executive Director
2	Mr. Scott T. Smith	CFO, Executive VP & Member of Executive Board
3	Ms. Pedersen Anni Lotte Kirstine Sonderbjerg	Executive VP, Chief Administrative Officer & Member of the Executive Board
4	Mr. Michael Wolff Jensen L.L.M.	Executive VP, Chief Legal Officer & Member of the Executive Board
5	Mr. Mads Bodenhoff	Senior VP, Head of Finance & Principal Accounting Officer
6	Mr. Chad Fugure	Vice President of Investor Relations
7	Mr. Flemming Steen Jensen	Executive Vice President of Product Supply & Quality
8	Dr. Kennett Sprogoe Ph.D.	Executive VP and Head of Research & Product Development
9	Mr. Joseph Kelly	Head of U.S. Commercial of Endocrinology
10	Ms. Sherrie Lynn Glass	Chief Business Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	RA Capital Management, LLC	16,75%	2,90 Mrd. USD
2	venBio Select Advisor LLC	8,25%	1,43 Mrd. USD
3	FMR Inc	6,32%	1,10 Mrd. USD
4	Franklin Templeton Inc	3,34%	0,58 Mrd. USD
5	Massachusetts Financial Services Company	3,03%	0,53 Mrd. USD
6	BlackRock Inc	1,08%	0,19 Mrd. USD
7	Polar Capital Holdings PLC	1,06%	0,18 Mrd. USD
8	Morgan Stanley - Brokerage Accounts	0,99%	0,17 Mrd. USD
9	The Goldman Sachs Group Inc	0,92%	0,16 Mrd. USD
10	Delaware Management Holdings Inc	0,91%	0,16 Mrd. USD
11	JPMorgan Chase & Co	0,88%	0,15 Mrd. USD
12	Ameriprise Financial Inc	0,78%	0,14 Mrd. USD
13	Fidelity International Ltd	0,73%	0,13 Mrd. USD
14	Vestal Point Capital LP	0,61%	0,11 Mrd. USD
15	Amvescap Plc.	0,59%	0,10 Mrd. USD
16	SEI Investments Co	0,57%	0,10 Mrd. USD
17	BNP Paribas Arbitrage, SA	0,50%	0,09 Mrd. USD
18	Fred Alger Management, LLC	0,50%	0,09 Mrd. USD
19	AllianceBernstein L.P.	0,45%	0,08 Mrd. USD
20	Candriam Luxembourg S.C.A.	0,38%	0,07 Mrd. USD